Neurology
Partner With Us
Advertisement
Conexiant chevron_right Neurology chevron_right Blood Biomarkers Conditionally Recommended for Alzheimers Diagnosis
Conference News Alzheimer’s Association International Conference (AAIC) 2024

Blood Biomarkers Conditionally Recommended for Alzheimer’s Diagnosis 

Clinical practice guideline sets performance thresholds for blood-based biomarkers to assist Alzheimer’s diagnosis in specialty care, with conditional support and emphasis on clinical context.

Conexiant
Full Article Summary Notecard
  1. Blood-based biomarkers aid in diagnosing Alzheimer's in cognitively impaired patients.
  2. Guidelines set thresholds for sensitivity (90%) and specificity (75%).
  3. Systematic review included 49 studies on 31 BBMs.
  4. Sensitivity and specificity varied significantly across tests.
  5. Clinicians urged to perform comprehensive evaluations before BBM tests.

Source: Alzheimer's & Dementia

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.